Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline Augmentation to Clozapine in Schizophrenia
NCT02124811Phase 4Completed
- Sponsor
- Emory University
- Start
- Feb 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of minocycline in schizophrenia, schizoaffective disorder, sponsored by Emory University. Started Feb 2015; status: completed.
02
Drugs
minocycline
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT02124811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02124811.